Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Long-lived assets by Year
Long-lived assets — Other countries outside U.S. & U.K. ($M) ($M)
Vertex Pharmaceuticals Long-lived assets: $27M in FY2025, up 73.1% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Segment & Geographic Information Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-lived assets — Other countries outside U.S. & U.K. ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 27 | +73.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 15.6 | -1.9% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 15.9 | +8.9% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 14.6 | -5.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 15.4 | +3.4% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 14.9 | +104.1% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 7.30 | +114.7% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 3.40 | -32.0% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 5 | – | Form 10-K (filed 2019-02-13) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Long-lived assets ($M), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/geo-lla-other
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.